Manning Paul B's Form 4 filing
Taysha Gene Therapies, Inc. (TSHA) · filed Jun 3, 2025
- Accession no.
- 0001415889-25-015480
- Filed
- Jun 3, 2025
- Trade date
- May 30, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.06M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manning Paul BCIK 0001494695 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Common Stock | PPurchaseAcquired | +750,000 | $2.75 | +$2,062,500 | 2,841,704 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.